Investing.com-- Life sciences giant Thermo Fisher Scientific (NYSE:TMO) is nearing a deal to acquire drug trial software maker Clario, valuing the healthcare technology firm at around $10 billion, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results